Da. Cameron et al., TAMOXIFEN INDUCED APOPTOSIS IN ZR-75 BREAST-CANCER XENOGRAFTS ANTEDATES TUMOR-REGRESSION, Breast cancer research and treatment, 45(2), 1997, pp. 99-107
The ZR-75-1 ER positive breast cancer cell line, xenografted in female
nude mice, has been used to determine the effect of tamoxifen on cell
proliferation (as measured by mitosis) and cell death (as evidenced b
y apoptosis and necrosis). After 2 days treatment, there was a signifi
cant rise in apoptosis (p < 0.05), whereas a fall in mitosis was not a
pparent until 7 days (p < 0.05). Furthermore there was an increase in
the apoptotic : mitotic ratio on day 7 (p < 0.05). These changes anted
ated tumour regression, which did reach not significance until day 14.
Tamoxifen did not increase necrosis (which significantly decreased in
treated tumours once they had regressed (p < 0.01)). In contrast tamo
xifen treatment of xenografted MDA-MB-231 ER-negative breast cancer ce
lls produced no significant effects on growth, apoptosis, or mitosis.
This study presents clear evidence for tamoxifen inducing apoptosis in
ZR-75-1 xenografts (but not MDA-MB-231 tumours). Since changes in apo
ptosis and mitosis antedate tumour regression, their assessment may pr
ovide the potential by which to predict tumour response to tamoxifen t
herapy.